Periprostetik eklem enfeksiyonu tanısında serolojik belirteçlerin değeri

Amaç: Bu çalışmanın amacı enfekte total kalça ve diz artroplastisi hastalarında pozitif ve negatif mikrobiyolojik kültür sonuçları ile mukayeseli olarak ESH ve CRP değerlerinin tanı koymadaki duyarlılık ve özgüllüğünü değerlendirmektir.Gereç ve Yöntem: Bu çalışmada enfekte total kalça veya total diz artroplastisi tanısı ile tedavi edilmiş toplam 80 hastanın klinik verileri retrospektif olarak değerlendirildi.Serum ESH ve CRP değerleri ile birlikte cerrahi olarak elde edilmiş mikrobiyolojik kültür sonuçları kaydedildi. 30 mm/saat üzerindeki ESH ve 10 mg/L üzerindeki CRP değerleri pozitif test olarak tanımlandı. Kültür sonuçları da pozitif ve negatif (steril) olarak sınıflandı.Bulgular: Çalışmada elde edilen verilere göre periprostetik enfeksiyon tanısında CRP'nin duyarlılığı %98 (%88 - %99 aralığında) ve özgüllüğü %0 (%0 - %15 aralığında); ESH'nin ise duyarlılığı %98 (%88 - %99 aralığında) ve özgüllüğü %7 (%1 - %15 aralığında) tespit edilmiştir.Sonuç: ESH ve CRPperiprostetik enfeksiyon tanısında yüksek duyarlılığa sahip değerli serolojik belirteçlerdir. Ortopedik cerrahlar yalancı pozitif sonuçlar olabileceğini göz önünde bulundurmalı ve gerekli görüldüğünde kesin tanı için ek yöntemler kullanılmalıdır.

Objective: The purpose of this study was to define the 'sensitivity' and 'specifity' of ESR and CRP values for the diagnosis of periprosthetic joint infection by comparing them with positive and negative microbiological cultures. Materials and Methods: We retrospectively analysed the data of 80 patients with the diagnosis of infected primary hip or knee arthroplasty, and noted ESR and CRP levelsas well as intraoperative microbiological culture results. ESR rates over 30 mm/h and CRP rates over 10 mg/dl were defined as positive test, and rates under these values defined as negative test. Culture results were also divided as negative (sterile) and positive.Results: According to our results, CRP had 98% sensitivity (ranges, 88% to 99 %) and 0 % specificity (ranges, 0 % to 15%) for the diagnosis periprosthetic infection; ESR had 98% sensitivity (ranges, 88% to 99 %) and 7 % specificity (ranges, 1% to 25 %) for the diagnosis periprosthetic infection. Conclusion: CRP and ESR tests are valuable and sensitive tests for the diagnosis of periprosthetic infection. On the other hand, orthopedic surgeons must be aware of false positive results of these tests and further investigation should be added for the definite diagnosis if needed.

___

  • 1. Lebwohl D, Canetta R. Clinical development of platinum complexes in cancer therapy: an historical perspective and an update. Eur J Cancer 1998;34:1522-34.
  • 2. Wang G, Reed E, Li QQ. Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer (Review). Oncology Reports 2004;12:955-65.
  • 3. Im GJ, Chang J, Lee S, Choi J, Jung HH, Lee HM, et al. Protective role of edaravone against cisplatin-induced ototoxicity in an auditory cell line. Hearing Res 2015;330:113-8.
  • 4. Jamshidzadeh A, Heidari R, Golzar T, Derakhshanfar A. Effect of Eisenia foetida Extract against Cisplatin-Induced Kidney Injury in Rats. J Diet Suppl 2016;13:551-9.
  • 5. Ateyya H, Yosef H, Nader MA. Ameliorative effect of trimetazidine on cisplatin-induced hepatotoxicity in rats. Can J Physiol Pharmacol 2015;19:1-6.
  • 6. Oz M, Nurullahoglu Atalik KE, Yerlikaya FH, Demir EA. Curcumin alleviates cisplatin-induced learning and memory impairments. Neurobiol Learn Mem 2015;123:43-9.
  • 7. Yin HL, Wang YL, Li J F, et al. Effects of curcumin on hippocampal expression of NgR and axonal regeneration in Abeta-induced cognitive disorder rats. Genetics and molecular research : GMR. 2014;13:2039-47.
  • 8. Sandur SK, Pandey MK, Sung B, Ahn KS, Murakami A, Sethi G, et al. Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis. 2007;28:1765-73.
  • 9. Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB. Curcumin and cancer: an "old-age" disease with an "age-old" solution. Cancer Letters 2008;267:133-64.
  • 10. Waseem M, Pandey P, Tomar B, Raisuddin S, Parvez S. Ameliorative action of curcumin in cisplatin-mediated hepatotoxicity: an in vivo study in Wistar rats. Arch Med Res 2014;45:462-8.
  • 11. Sidhu GS, Mani H, Gaddipati JP, et al. Curcumin enhances wound healing in streptozotocin induced diabetic rats and genetically diabetic mice. Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society 1999;7:362-74.
  • 12. Wang Z, Zhang Q, Yuan L, et al. The effects of curcumin on depressive-like behavior in mice after lipopolysaccharide administration. Behav Brain Res 2014;274:282-90.
  • 13. Imbaby S, Ewais M, Essawy S, Farag N. Cardioprotective effects of curcumin and nebivolol against doxorubicin-induced cardiac toxicity in rats. Hum Exp Toxicol 2014;33:800- 13.
  • 14. Mishra S, Palanivelu K. The effect of curcumin (turmeric) on Alzheimer's disease: An overview. Ann Indian Acad Neurol 2008;11:13-9.
  • 15. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. The Journal of biological chemistry. 1951;193:265-75.
  • 16. Erken HA, Koc ER, Yazici H, Yay A, Onder GO, Sarici SF. Selenium partially prevents cisplatin-induced neurotoxicity: a preliminary study. Neurotoxicology 2014;42:71-5.
  • 17. Ugur S, Ulu R, Dogukan A, Gurel A, Yigit IP, Gozel N, et al. The renoprotective effect of curcumin in cisplatin-induced nephrotoxicity. Renal Failure 2015;37:332-6.
  • 18. Ehlert U, Gaab J, Heinrichs M. Psychoneuroendocrinological contributions to the etiology of depression, posttraumatic stress disorder, and stress-related bodily disorders: the role of the hypothalamus-pituitary-adrenal axis. Biological Psychology 2001;57:141-52.
  • 19. Weaver IC, La Plante P, Weaver S, et al. Early environmental regulation of hippocampal glucocorticoid receptor gene expression: characterization of intracellular mediators and potential genomic target sites. Mol Cell Endocrinol 2001;185:205-18.
  • 20. de Kloet ER, Joels M, Holsboer F. Stress and the brain: from adaptation to disease. Nature reviews Neuroscience 2005;6:463-75.
  • 21. Kellendonk C, Gass P, Kretz O, Schutz G, Tronche F. Corticosteroid receptors in the brain: gene targeting studies. Brain Res Bull 2002;57:73-83.
  • 22. van Haarst AD, Oitzl MS, de Kloet ER. Facilitation of feedback inhibition through blockade of glucocorticoid receptors in the hippocampus. Neurocheem Res 1997;22:1323-8.